Search Results

Showing results 2771 - 2780 for Weill Cornell patient portal

Funding and Equity for University Startups: Valuation and Term Sheets | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/events/funding-and-equity-university-startups-valuation-and-term-sheets

Methods and Reagents for Analyzing Riboswitches | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/methods-and-reagents-analyzing-riboswitches

Motion Organized Simultaneous Acquisition with Interactive Control for Real-Time | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/motion-organized-simultaneous-acquisition

Bone-Marrow Derived Hematopoietic Progenitor Cells and Endothelial Progenitor Cells as Prognostic Indicators for Cancer Relapse | Enterprise Innovation

...Weill Cornell Medicine © Weill Cornell Medicine....

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/bone-marrow-derived-hematopoietic-progenitor-cells

A Triple Staining Assay to Diagnose Prostate Cancer | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/triple-staining-assay-diagnose-prostate-cancer

New Ribosomal Target for Antibiotic Drug Discovery | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/new-ribosomal-target-antibiotic-drug-discovery

Single Molecule Imaging Techniques to Aid Crystallization | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/single-molecule-imaging-techniques-aid

ApoM Complex Inhibits Endothelial Cell Injuries | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/apom-complex-inhibits-endothelial-cell-injuries

Pan-PPAR Agonists for the Treatment of Tauopathies and Huntington's Disease | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/pan-ppar-agonists-treatment-tauopathies-and

Purine Receptor P2Y Modulators as CNS Therapeutics and In Stem Cell Maintenance and Differentiation | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/purine-receptor-p2y-modulators-cns-therapeutics-and

Showing results 2771 - 2780 for Weill Cornell patient portal